c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
Biohaven (BHVN) Reports Promising Phase 1 Data for BHV-1530 Targeting FGFR3-Altered Cancers
GuruFocus | Nov 19, 2026 8:26 AM EST
Related Stocks: BHVN ,
Read original article